Partnership Potential There is a history of strategic partnerships with health tech and diagnostics (Secure AI Labs, Sano Genetics, Fibronostics) suggesting FLF is open to collaboration that expands reach, improves screening, and adds new patient-facing tools. This indicates opportunities to propose integrated programs with clinics, labs, and health tech vendors that align with NAFLD/NASH education and early detection.
Awareness Programs FLF actively runs national initiatives like The State of NAFLD/NASH Care in America, signaling a need for audience growth, survey data, and care pathway insights. Sales opportunities include providing research partners, data collection services, or sponsored content and educational resources to widen impact and attract funders or corporate sponsors.
Digital Outreach Existing tech stack includes Google Ads, Calendly, Cloudinary, Cookiebot, Google Workspace, monday.com, PayPal, and Zoom, indicating strong affinity for scalable digital campaigns and streamlined events. Propose integrated marketing services, donor acquisition programs, and virtual health events or screenings powered by these platforms to drive engagement and fundraising.
Funding Upsell With annual revenue in the low seven figures and a clear nonprofit focus, FLF may benefit from expanded sponsorships, grant-ready programs, and corporate CSR partnerships in health tech, chronic disease prevention, and liver health. Tailored sponsorship packages and grant-writing support could unlock additional revenue streams.
Global Collaboration Past international-oriented partnerships (e.g., Sano Genetics) and a mission to educate Americans about NAFLD/NASH present an opportunity to offer international screening and genetic risk assessment partnerships, licensing educational content, or joint research initiatives that broaden FLF’s impact and revenue possibilities.